HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inge Kroidl Selected Research

Inge Kroidl Research Topics

Disease

7Infections
01/2022 - 01/2018
5Tuberculosis (Tuberculoses)
01/2018 - 01/2012
3COVID-19
01/2022 - 01/2021
3Filarial Elephantiasis (Lymphatic Filariasis)
03/2020 - 04/2016
2Elephantiasis
07/2021 - 03/2020
2Coinfection
08/2016 - 04/2016
2Proteinuria
09/2015 - 08/2009
2Spotted Fever Group Rickettsiosis (Rickettsialpox)
04/2015 - 01/2014
1Communicable Diseases (Infectious Diseases)
07/2021
1Hepatitis B
01/2021
1Breakthrough Infections
01/2021
1Hepatitis C
01/2021
1Disease Progression
06/2020
1Malaria
06/2018
1Rift Valley Fever
01/2014
1Pulmonary Tuberculosis
08/2009

Drug/Important Bio-Agent (IBA)

5AntibodiesIBA
01/2022 - 04/2015
3lipoarabinomannan (LAM)IBA
09/2015 - 08/2009
2VaccinesIBA
07/2021 - 06/2020
2AntigensIBA
01/2021 - 01/2021
2Interferon-gamma (Interferon, gamma)IBA
01/2021 - 01/2018
2Tuberculin (PPD)IBA
01/2018 - 01/2012
2Ivermectin (Mectizan)FDA Link
08/2016 - 04/2016
2Albendazole (Albenza)FDA Link
08/2016 - 04/2016
2Immunoglobulin G (IgG)IBA
04/2015 - 01/2014
2GoldIBA
04/2013 - 01/2012
1Antiviral Agents (Antivirals)IBA
01/2022
1InterferonsIBA
01/2022
1ClayIBA
07/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Hepatitis delta Antigens (HDAg)IBA
01/2021
1BNT162 VaccineIBA
01/2021
1Doxycycline (Periostat)FDA LinkGeneric
03/2020
1artemisinin (artemisinine)IBA
06/2018
1Biomarkers (Surrogate Marker)IBA
01/2018

Therapy/Procedure

1Immunomodulation
01/2022
1Drug Therapy (Chemotherapy)
03/2020
1Therapeutics
06/2018